4-bromo-a-23187 has been researched along with halothane in 2 studies
| Studies (4-bromo-a-23187) | Trials (4-bromo-a-23187) | Recent Studies (post-2010) (4-bromo-a-23187) | Studies (halothane) | Trials (halothane) | Recent Studies (post-2010) (halothane) |
|---|---|---|---|---|---|
| 63 | 0 | 5 | 14,369 | 884 | 235 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berggren, M; Iaizzo, PA; Melder, DC; Olsen, RA; Powis, G; Seewald, MJ | 1 |
| Melder, DC; Olsen, RA; Powis, G; Schlager, JJ; Seewald, MJ | 1 |
2 other study(ies) available for 4-bromo-a-23187 and halothane
| Article | Year |
|---|---|
Platelet-derived growth factor blocks the increase in intracellular free Ca2+ caused by calcium ionophores and a volatile anesthetic agent in Swiss 3T3 fibroblasts without altering toxicity.
Topics: Aequorin; Calcimycin; Calcium; Cells, Cultured; Fibroblasts; Halothane; Ionomycin; Ionophores; Platelet-Derived Growth Factor | 1991 |
High molecular weight dextran sulfate inhibits intracellular Ca2+ release and decreases growth factor-induced increases in intracellular free Ca2+ in Swiss 3T3 fibroblasts.
Topics: Arachidonic Acid; Arachidonic Acids; Arginine Vasopressin; Bradykinin; Calcimycin; Calcium; Cells, Cultured; Dextran Sulfate; Dextrans; Fibroblasts; Guanosine Triphosphate; Halothane; Heparin; Inositol 1,4,5-Trisphosphate; Mitogens; Molecular Weight; Platelet Activating Factor; Receptors, Cell Surface | 1989 |